Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases

[Caribou Biosciences @CaribouBio]

Don’t miss the fireside chat with our president and CEO, Rachel Haurwitz, PhD, at the @Jefferies Global Healthcare Conference tomorrow.

Listen in to the webcast here: https://t.co/4EfzvCHH8d #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

We’re heading to New York for the @Jefferies Global Healthcare Conference.

Learn more: https://t.co/8vyyveUVD8 #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Caribou is participating in the @HCWCO 4th Annual BioConnect Investor Conference. Tune in to the fireside chat tomorrow with our CMO, Tina Albertson, and our CFO, Sri Ryali.

Access the webcast here: https://t.co/AKIEMgjmwI #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Heading to NYC next week for the @HCWCO 4th Annual BioConnect Investor Conference.

Learn more: https://t.co/CysfPxnq2j #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Join us at #EHA2026 for two oral presentations on our allogeneic CAR-T cell therapy programs: vispa-cel for #lymphoma and CB-011 for #multiplemyeloma!

Learn more: https://t.co/pkPe8rb0Fp #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Don’t miss our upcoming fireside chat with our president and CEO, Rachel Haurwitz, PhD, at the @BankofAmerica Securities Health Care Conference.

Tune into the webcast here: https://t.co/Grc0855r7D #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

In Boston? Check out the #ASGCT2026 session on homology-directed genome repair where Enrique Zudaire, PhD, will discuss how our chRDNA genome-editing technology is used to armor allogeneic CAR-T cells for enhanced antitumor activity.

Learn more: https://t.co/ICSbt9OSFF $CRBU

[Caribou Biosciences @CaribouBio]

We reported that we achieved alignment with the FDA regarding the vispa-cel pivotal trial design. Read more about this business update and our first quarter 2026 financial results here: https://t.co/DVMEsghfvi #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Join our president and CEO, Rachel Haurwitz, PhD, next week for a fireside chat at the BofA Securities Health Care Conference in Las Vegas. Learn more: https://t.co/jTpP7lGPlv #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Clinical trials play a vital role in advancing the future of myeloma care.

As we close out #MyelomaActionMonth, Dr. Luciano Costa shares his perspective on the importance of clinical trials: https://t.co/D3KulaqmsG

#MoreThanMyeloma

[Caribou Biosciences @CaribouBio]

We are pleased to announce the FDA has granted RMAT designation to CB-011 for relapsed or refractory multiple myeloma.

Learn more: https://t.co/7gHcM70aoK #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

On #WorldMyelomaDay, we are grateful to the courageous patients who participate in our clinical trials for heme malignancies. Today, we are honored to be able to share Dale’s story with you.

Watch the full video: https://t.co/DVcqowDjgB

#MoreThanMyeloma #MyelomaActionMonth

[Caribou Biosciences @CaribouBio]

We’re looking forward to the @Myeloma_Society’s 7th Immune Effector Cell Therapies in Multiple Myeloma Workshop!

Dr. Adriana Rossi will be presenting our recently disclosed data from the CaMMouflage trial for CB-011. #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Don’t miss the fireside chat tomorrow with our CMO, Tina Albertson, and our CFO, Sri Ryali, at the @Leerink Partners Global Healthcare Conference.

Tune into the webcast here: https://t.co/4zPzbBU4bc #CellTherapy #CRISPR

[Caribou Biosciences @CaribouBio]

Today, we reported our Q4 and FY2025 financial results. Learn more: https://t.co/xk0K4AJt6k #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

#ICYMI a replay of @BloodCancerUtd's TAP panel with Caribou’s CMO, Tina Albertson, MD, PhD is now available online.

Watch to hear how Caribou is developing off-the-shelf CAR-T cell therapies to broaden patient access. https://t.co/lA8B70Iwqs

[Caribou Biosciences @CaribouBio]

We’ll be attending the @Citi 2026 Virtual Oncology Leadership Summit and @LeerinkPartners Global Healthcare Conference in the coming weeks.

Learn more: https://t.co/VIik6C3rHO

#CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

If you’re in San Diego for #AdvancedTherapiesWeek, don’t miss talks from Justin Skoble, PhD, Caribou’s vice president of technical operations.

See you there! #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Caribou will be at @ASTCT presenting translational data for the ANTLER and CaMMouflage allogenic CAR-T cell therapy clinical trials.

Read more here: https://t.co/bQbuQqesCN #CellTherapy #CRISPR $CRBU

[Caribou Biosciences @CaribouBio]

Don’t miss @BloodCancerUtd’s Therapy Acceleration Program annual expert panel, including our CMO, Tina Albertson, MD, PhD.

Register here: https://t.co/teiaefJ4vz   #CellTherapy #CRISPR $CRBU